Evidence map›Paper›PMID 27779697›Full record

ArticleOncology reports2016

Myofibroblast distribution is associated with invasive growth types of colorectal cancer.

Masafumi Takatsuna, Satoko Morohashi, Tadashi Yoshizawa, Hideaki Hirai, Toshihiro Haga, Rie Ota, Kensuke Saito, Yunyan Wu, Hiroko Seino, Yutaka Aoyagi and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Oncology reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Masafumi TakatsunaDepartment of Pathology and Bioscience, Hirosaki University Graduate School of Medicine, Hirosaki 036‑8562, Japan.
Satoko MorohashiDepartment of Pathology and Bioscience, Hirosaki University Graduate School of Medicine, Hirosaki 036‑8562, Japan.
Tadashi YoshizawaDepartment of Pathology and Bioscience, Hirosaki University Graduate School of Medicine, Hirosaki 036‑8562, Japan.
Hideaki HiraiDepartment of Pathology and Bioscience, Hirosaki University Graduate School of Medicine, Hirosaki 036‑8562, Japan.
Toshihiro HagaDepartment of Pathology and Bioscience, Hirosaki University Graduate School of Medicine, Hirosaki 036‑8562, Japan.
Rie OtaDepartment of Pathology and Bioscience, Hirosaki University Graduate School of Medicine, Hirosaki 036‑8562, Japan.
Kensuke SaitoDepartment of Pathology and Bioscience, Hirosaki University Graduate School of Medicine, Hirosaki 036‑8562, Japan.
Yunyan WuDepartment of Pathology and Bioscience, Hirosaki University Graduate School of Medicine, Hirosaki 036‑8562, Japan.
Hiroko SeinoDepartment of Pathology and Bioscience, Hirosaki University Graduate School of Medicine, Hirosaki 036‑8562, Japan.
Yutaka AoyagiDepartment of Gastroenterology, Niigata Medical Center, Niigata Prefectural Federation of Agricultural Cooperatives for Health and Welfare, Nishi-ku, Niigata 950-2022, Japan.
Shuji TeraiDivision of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Chuo-ku, Niigata 951-8510, Japan.
Hiroshi KijimaDepartment of Pathology and Bioscience, Hirosaki University Graduate School of Medicine, Hirosaki 036‑8562, Japan.
Hirosaki University · JPNiigata University · JPNiigata University of Health and Welfare · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Both the invasive growth types of colorectal cancer (CRC) and the number of myofibroblasts have been associated with histopathological factors such as lymph node and liver metastasis, and local recurrence. However, there are few studies, that have assessed the association between invasive growth type and myofibroblast distribution in CRC. We aimed to evaluate the relationship between the clinicopathological factors of CRC and two invasive growth types, the expanding and infiltrating types. We categorized 150 cases of pT3 CRC into the expanding and infiltrating types and measured the myofibroblast density of three histological layers: the submucosa (SM), the muscularis propria (MP) and the subserosa (SS). We compared these two invasive growth types and analyzed the relationship between clinicopathological factors and myofibroblast density. Myofibroblast density was significantly higher in the infiltrating type than that in the expanding type (P<0.05). In the lymph node metastasis-positive group of the infiltrating type, myofibroblast density in MP was significantly higher than that in the lymph node metastasis-negative group (P<0.001). In the infiltrating type, the group with the higher level of lymphatic invasion had a significantly higher density of myofibroblasts in the MP than the group with the lower level of lymphatic invasion (P<0.01). These results suggest that myofibroblasts participate more in the infiltrating type compared with the expanding type of CRC. It would appear that myofibroblasts present in the MP play an important role in the malignant potential of the infiltrating type compared to the expanding type.

Indexed as

AdenocarcinomaAdultAgedAged, 80 and overColorectal NeoplasmsFemaleHumansLymphatic MetastasisLymphatic VesselsMaleMiddle AgedMyofibroblastsNeoplasm Invasiveness

Identifiers

PMID27779697
PMCPMC5112613
OpenAlexW2538740858

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.